Reference Guidance Programme Topic
QS113 Healthcare-associated infections
Quality standard
QS114 Irritable bowel syndrome in adults
Quality standard
NG35 Myeloma: diagnosis and management
Guideline
Blood and bone marrow cancers
DG20 Tests for rapidly identifying bloodstream bacteria and fungi (LightCycler SeptiFast Test MGRADE, SepsiTest and IRIDICA BAC BSI assay)
Diagnostics guidance
Infections: general and other
NG36 Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and over
Guideline
Head and neck cancers
NG34 Sunlight exposure: risks and benefits
Guideline
Skin cancer
TA383 TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis
Technology appraisal guidance
Arthritis
NG33 Updated  Tuberculosis
Guideline
Infectious disease prevention and control
QS10 Updated  Chronic obstructive pulmonary disease in adults
Quality standard
Chronic obstructive pulmonary disease
PH32 Updated  Skin cancer prevention
Public health guideline
Skin cancer
QSD In development  Domestic violence and abuse
Quality standard
Vulnerable groups
MTA In development  Ankylosing spondylitis and axial spondyloarthritis (non-radiographic) - adalimumab, certolizumab pegol, etanercept, golimumab and infliximab (inc rev TA143 and TA233) ID694
Technology appraisal guidance
STA In development  Melanoma (advanced, unresectable, metastatic) - nivolumab [ID845]
Technology appraisal guidance
Skin cancer
CG In development  Attention deficit hyperactivity disorder (standing committee B update)
Guidelines
Children and young people
DT In development  Crohn's disease - Tests for therapeutic monitoring of TNF inhibitors (LISA-TRACKER ELISA kits, TNFa-Blocker ELISA kits, and Promonitor ELISA kits)
Diagnostics guidance
Inflammatory bowel disease
DT In development  Type 1 diabetes: Integrated sensor-augmented pump therapy systems for managing blood glucose levels (The MiniMed Paradigm Veo System and the Vibe and G4 PLATINUM CGM system)
Diagnostics guidance
Diabetes
CG In development  Motor Neurone Disease
Guidelines
Motor neurone disease
CG In development  Fractures
Guidelines
Trauma
CG In development  Major trauma services
Guidelines
Trauma
CG In development  Complex fractures
Guidelines
Trauma
CG In development  Major trauma
Guidelines
Trauma
STA In development  Myelofibrosis (splenomegaly, symptoms) - ruxolitinib (review TA289) [ID831]
Technology appraisal guidance
Blood conditions
CG In development  Spinal injury assessment
Guidelines
Trauma
QSD In development  Chronic heart failure in adults
Quality standard
Heart failure
MTA In development  Kidney transplantation (children, adolescents) - immunosuppressive regimens (review of TA99) [ID346]
Technology appraisal guidance
Kidney conditions: general and other
MTA In development  Kidney transplantation (adults) - immunosuppressive therapy (review of TA 85) [ID456]
Technology appraisal guidance
Kidney conditions: general and other
STA In development  Hypercholesterolaemia - ezetimibe (review TA132) [ID627]
Technology appraisal guidance
Lipid disorders
SC In development  Transition from children's to adults' services
Unclassified
Adult social services